![]() |
CiteULike | ![]() |
shimi002's CiteULike | ![]() |
![]() |
|
![]() |
Register | ![]() |
Log in | ![]() |
Modulation of CD103 Expression on Human Colon Carcinoma-Specific CTL |
Reviews
[Write a review of this article]
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
Posting History
AbstractRecent results have shown a correlation between survival and frequency of tumor-infiltrating T cells in colorectal cancer patients. However, the mechanisms controlling the ability of human T lymphocytes to infiltrate colon carcinoma remain unclear. Although, it is known that expression of the integrin CD103alphaE/[beta]7 by intraepithelial lymphocytes controls the retention of lymphocytes in epithelial layers, very little is known about the expression of intestinal homing receptors in human T lymphocytes. In particular, it remains unknown whether expression of CD103/[beta]7 by human colon cancer-specific T lymphocytes is controlled by recognition of tumor Ags and is imprinted during T cell priming, facilitating its expression during memory T cell activation. In this study, we demonstrate that expression of CD103/[beta]7 in human colon carcinoma-specific CTL is synergistically enhanced by the simultaneous TGF-[beta]1 stimulation and Ag recognition. These results were confirmed by using a panel of human CTL clones. Finally, we show that priming of naive CD8+ T cells in the presence of TGF-[beta]1 ensures up-regulation of CD103/[beta]7 in recall responses, at concentrations of TGF-[beta]1 significantly lower than those required by memory T cells primed in the absence of TGF-[beta]1. These results indicate a role of TGF-[beta]1 during T cell priming in modulating expression of CD103/[beta]7 and controlling retention of human memory CD8+ T cells into tumor epithelium.
BibTeX record
RIS record